Physician profile
Imran Solaiman
NPI 1659638898
$389.45
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2022: $24.66 · 2023: $81.08 · 2024: $20.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $56.18 | 2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $50.00 | 2019 | |
| Abbott Laboratories | $49.56 | 2022-2023 | Freestyle Libre 3 |
| Amgen INC. | $31.37 | 2019 | |
| Intuitive Surgical, INC. | $31.13 | 2019 | |
| Lilly USA, LLC | $30.93 | 2019 | |
| Glaxosmithkline, LLC. | $25.02 | 2019 | |
| Amarin Pharma, INC. | $23.44 | 2019 | |
| Philips North America LLC | $20.28 | 2024 | (Ck7) Extended Holter |
| Ultragenyx Pharmaceutical INC. | $16.43 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.66 | 2019 | |
| Novo Nordisk INC | $15.08 | 2019 | |
| Merck Sharp & Dohme LLC | $12.45 | 2019 | |
| Shire North American Group INC | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Solaiman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.